New treatment for COVID-19: our surfactant therapy works well



[ad_1]

Dr. Vasilka Zarcheva and Dr. Chavdar Botev Staff: NOVA

Surfactant therapy, administered by a Bulgarian medical team, works well in treating COVID-19. This was announced to NOVA by Dr. Vasilka Zarcheva and Dr. Chavdar Botev.

In our country, life-saving surfactant therapy has been used for 20 years and has been applied to more than 15,000 children who have survived, said Dr. Zarcheva.

COVID-19 is a new disease and each therapy is carried out as a protocol for a new infection. Even under Trump, doctors believe his life is in danger and use an unapproved therapy, such as an antibody cocktail, Dr. Chavdar Botev told NOVA.

Dr. Botev and Dr. Zarcheva talked about a new type of treatment for COVID-19, which may be decisive for the future.

Surfactant according to 3 indicators destroys the coronavirus, which intelligently enters cells: the first viruses die, but the others destroy the cell, Botev noted.

He pointed out that the known preparations in our country bromhexine and ambroxol, as well as vitamin D, also work successfully to destroy the virus envelope.

Surfactant is a mixture of proteins and lipids that is produced in the pneumocytes in the lungs. Its synthesis is established in the sixth month after the beginning of pregnancy, explained Dr. Vasilka Zarcheva.

He adds that in premature babies it is absent or in very small amounts, which is not enough. Therefore, children have very severe respiratory failure and the use of surfactant on them saves their lives.

Dr. Zarcheva explains that COVID-19 affects the lungs very severely and alters their synthesis. This is the reason why some patients develop respiratory failure incompatible with life.

Regardless of the ventilation of the hardware, its condition is not restored. This leads to damage to other organs and systems, “says Zarcheva.

Dr. Botev adds that evolutionarily, this virus has adapted to surfactant.

“Vitamin D has been shown to lead to an increase in surfactant,” says Botev.



[ad_2]